GGrantIndex
← Leaderboards

Christina Gross

Cincinnati Childrens Hosp Med Ctr

$5,984,277
Attributed
$6,385,902
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $785.1K · FY201425
$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,385,902 · 8

By mechanism

R01$4,231,651 · 3
R21$2,154,251 · 5

Top collaborators

Most similar at Cincinnati Childrens Hosp Med Ctr

Same institution · by research overlap

Others in their field

Top investigators on “Mediating

Research focus

MediatingMolecularTreatment StrategyMouse ModelBrainComplexMessenger RnaPreventTherapeutic TargetEpilepsyPharmaceutical PreparationsSeizuresAffectPathway InteractionsGeneticPredispositionCellsPublic HealthNeuronsTranslationsFrequenciesMicrornasLeadFuture

Grant awards (23)

Cell type-specific epigenetic control of brain function$579,294
R01 · FY2025 · NS · contact PI
Functional analysis of the microRNA-induced silencing complex in epilepsy$337,379
R01 · FY2024 · NS · contact PI
Functional analysis of the microRNA-induced silencing complex in epilepsy$347,813
R01 · FY2023 · NS · contact PI
Assessing the contribution of altered PI3K signaling to breathing abnormalities and sudden death in epilepsy$238,500
R21 · FY2023 · NS · contact PI
Cell type-specific functions of microRNA in epilepsy$198,750
R21 · FY2023 · NS · contact PI
Functional analysis of the microRNA-induced silencing complex in epilepsy$347,813
R01 · FY2022 · NS · contact PI
Cell type-specific functions of microRNA in epilepsy$238,500
R21 · FY2022 · NS · contact PI
Assessing the contribution of altered PI3K signaling to breathing abnormalities and sudden death in epilepsy$198,750
R21 · FY2022 · NS · contact PI
Functional analysis of the microRNA-induced silencing complex in epilepsy$347,813
R01 · FY2021 · NS · contact PI
Functional analysis of the microRNA-induced silencing complex in epilepsy$124,901
R01 · FY2021 · NS · contact PI
Functional analysis of the microRNA-induced silencing complex in epilepsy$347,813
R01 · FY2020 · NS · contact PI
MicroRNA-mediated silencing of the Kv4.2 complex in epilepsy$341,250
R01 · FY2020 · NS · contact PI
MicroRNA-mediated silencing of the Kv4.2 complex in epilepsy$341,250
R01 · FY2019 · NS · contact PI
Mechanism-targeted treatment strategy in PTEN-associated autism and epilepsy$199,524
R21 · FY2019 · HD · contact PI
MicroRNA-mediated silencing of the Kv4.2 complex in epilepsy$341,250
R01 · FY2018 · NS · contact PI
Mechanism-targeted treatment strategy in PTEN-associated autism and epilepsy$253,204
R21 · FY2018 · HD · contact PI
MicroRNA-mediated silencing of the Kv4.2 complex in epilepsy$341,250
R01 · FY2017 · NS · contact PI
MicroRNA-mediated silencing of the Kv4.2 complex in epilepsy$102,375
R01 · FY2017 · NS · contact PI
MicroRNA-mediated silencing of the Kv4.2 complex in epilepsy$331,450
R01 · FY2016 · NS · contact PI
Selective targeting of P13K to restore higher cognitive function in FXS$203,876
R21 · FY2015 · MH · contact PI
Targeting the PI3K Enhancer PIKE to Reverse FXS-associated Phenotypes$160,000
R21 · FY2015 · MH
Selective targeting of P13K to restore higher cognitive function in FXS$257,147
R21 · FY2014 · MH · contact PI
Targeting the PI3K Enhancer PIKE to Reverse FXS-associated Phenotypes$206,000
R21 · FY2014 · MH